Risperidone and Intracranial pressure increased - a phase IV clinical study of FDA data


Intracranial pressure increased is found among people who take Risperidone, especially for people who are female, 10-19 old, have been taking the drug for 1 - 6 months.

The phase IV clinical study analyzes which people take Risperidone and have Intracranial pressure increased. It is created by eHealthMe based on reports of 61,258 people who have side effects when taking Risperidone from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

61,258 people reported to have side effects when taking Risperidone.
Among them, 52 people (0.08%) have Intracranial pressure increased.

What is Risperidone?

Risperidone has active ingredients of risperidone. It is often used in bipolar disorder. eHealthMe is studying from 62,590 Risperidone users for its effectiveness, alternative drugs and more.

What is Intracranial pressure increased?

Intracranial pressure increased (high pressure inside the skull and thus in the brain tissue and cerebrospinal fluid) is found to be associated with 1,157 drugs and 704 conditions by eHealthMe.

Number of Risperidone and Intracranial pressure increased reports submitted per year:

Could Risperidone cause Intracranial pressure increased?

Time on Risperidone when people have Intracranial pressure increased *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 100 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Intracranial pressure increased when taking Risperidone *:

  • female: 82 %
  • male: 18 %

Age of people who have Intracranial pressure increased when taking Risperidone *:

  • 0-1: 0.0 %
  • 2-9: 6.38 %
  • 10-19: 74.47 %
  • 20-29: 4.26 %
  • 30-39: 2.13 %
  • 40-49: 12.77 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common drugs people take besides Risperidone *:

  1. Lithium Carbonate: 2 people, 3.85%
  2. Haloperidol: 2 people, 3.85%
  3. Spironolactone: 1 person, 1.92%
  4. Drisdol: 1 person, 1.92%
  5. Afinitor: 1 person, 1.92%
  6. Aldactone: 1 person, 1.92%
  7. Aldurazyme: 1 person, 1.92%
  8. Ativan: 1 person, 1.92%
  9. Benadryl: 1 person, 1.92%
  10. Celexa: 1 person, 1.92%

Common side effects people have besides Intracranial pressure increased *:

  1. Weight Increased: 26 people, 50.00%
  2. Headache (pain in head): 14 people, 26.92%
  3. Papilloedema (optic disc swelling): 12 people, 23.08%
  4. Diplopia (double vision): 10 people, 19.23%
  5. Blindness: 7 people, 13.46%
  6. Suicidal Ideation: 5 people, 9.62%
  7. Cerebrovascular Stenosis (narrowing of brain blood vessels): 5 people, 9.62%
  8. Brain Oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain): 4 people, 7.69%
  9. Cerebrospinal Fluid Leakage: 3 people, 5.77%
  10. Csf Pressure Increased: 3 people, 5.77%

Common conditions people have *:

  1. Hallucination, Auditory (perceiving sounds without auditory stimulus): 18 people, 34.62%
  2. Asthma: 16 people, 30.77%
  3. Bipolar I Disorder (mood disorder that is characterized by at least one manic or mixed episode): 5 people, 9.62%
  4. Hypomania (a mild form of mania, marked by elation and hyperactivity): 2 people, 3.85%
  5. Stress And Anxiety: 1 person, 1.92%
  6. Sleep Disorder: 1 person, 1.92%
  7. Rickets (softening of bones): 1 person, 1.92%
  8. Autism (a mental condition, present from early childhood, characterized by difficulty in communicating and forming relationships with other people and in using language and abstract concepts): 1 person, 1.92%
  9. Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 1 person, 1.92%
  10. Astrocytoma (tumour of the brain that originate in a particular kind of glial-cells): 1 person, 1.92%

* Approximation only. Some reports may have incomplete information.

Do you take Risperidone and have Intracranial pressure increased?

Check whether Intracranial pressure increased is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

How severe was Intracranial pressure increased and when was it recovered:

Expand to all the drugs that have ingredients of risperidone:

Alternative drugs to, pros and cons of Risperidone:

Common Risperidone side effects:

Browse all side effects of Risperidone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Intracranial pressure increased treatments and more:

COVID vaccines that are related to Intracranial pressure increased:

Common drugs associated with Intracranial pressure increased:

All the drugs that are associated with Intracranial pressure increased:

Common conditions associated with Intracranial pressure increased:

All the conditions that are associated with Intracranial pressure increased:

How the study uses the data?

The study uses data from the FDA. It is based on risperidone (the active ingredients of Risperidone) and Risperidone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: